Literature DB >> 20144628

Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population.

Christopher M Triggs1, Karen Munday, Rong Hu, Alan G Fraser, Richard B Gearry, Murray L Barclay, Lynnette R Ferguson.   

Abstract

Diet is known to play a major role in the symptoms of the inflammatory bowel disease, Crohn's disease (CD). Although no single diet is appropriate to all individuals, most CD patients are aware of foods that provide adverse or beneficial effects. This study seeks to categorise foods in relation to their effects on symptoms of CD, in a New Zealand Caucasian population. Four hundred and forty-six subjects from two different centres in New Zealand were recruited into the study. An extensive dietary questionnaire (257 food items in 15 groups) recorded self-reported dietary tolerances and intolerances. Across each of the food groups, there were statistically significant differences among responses to foods. A two-dimensional graphical summary enabled stratification of foods according to the probability that they will be either beneficial or detrimental. A small number of foods are frequently considered to be beneficial, including white fish, salmon and tuna, gluten-free products, oatmeal, bananas, boiled potatoes, sweet potatoes (kumara), pumpkin, soya milk, goat's milk and yoghurt. Foods that are typically considered detrimental include grapefruit, chilli or chilli sauce, corn and corn products, peanuts, cream, salami, curried foods, cola drinks, high energy drinks, beer, and red wine. For a number of the food items, the same item that was beneficial for one group of subjects was detrimental to others; in particular soya milk, goat's milk, yoghurt, oatmeal, kiwifruit, prunes, apple, broccoli, cauliflower, linseed, pumpkin seed, sunflower seed, ginger and ginger products, beef, lamb, liver, and oily fish. It was not possible to identify a specific group of food items that should be avoided by all CD patients. The wide range of detrimental items suggests that dietary maintenance of remission is likely to be difficult, and to exclude a substantial number of foods. Personalised diets may be especially important to these individuals.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20144628     DOI: 10.1016/j.mrfmmm.2010.01.020

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  26 in total

1.  Why might the finding of a new genetic association with inflammatory bowel disease be of potential value in disease control?

Authors:  Lynnette R Ferguson
Journal:  Am J Clin Nutr       Date:  2017-11-08       Impact factor: 7.045

Review 2.  Psychological Considerations and Interventions in Inflammatory Bowel Disease Patient Care.

Authors:  Tiffany H Taft; Sarah Ballou; Alyse Bedell; Devin Lincenberg
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

Review 3.  Potential value of nutrigenomics in Crohn's disease.

Authors:  Lynnette R Ferguson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-13       Impact factor: 46.802

4.  Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Livia Guadagnoli; Ece A Mutlu; Bethany Doerfler; Ammoura Ibrahim; Darren Brenner; Tiffany H Taft
Journal:  Qual Life Res       Date:  2019-03-21       Impact factor: 4.147

5.  Alcohol Use in Patients With Inflammatory Bowel Disease.

Authors:  Guilherme Piovezani Ramos; Sunanda Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-05

Review 6.  Food-related quality of life in inflammatory bowel disease: measuring the validity and reliability of the Turkish version of FR-QOL-29.

Authors:  Nazlı Nur Aslan Çin; Kevin Whelan; Ayşe Özfer Özçelik
Journal:  Health Qual Life Outcomes       Date:  2022-07-05       Impact factor: 3.077

Review 7.  Why interleukin-10 supplementation does not work in Crohn's disease patients.

Authors:  Gareth J Marlow; Dominique van Gent; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

8.  Lactose Intolerance Assessed by Analysis of Genetic Polymorphism, Breath Test and Symptoms in Patients with Inflammatory Bowel Disease.

Authors:  Olga Maria Nardone; Francesco Manfellotto; Caterina D'Onofrio; Alba Rocco; Giovanni Annona; Francesca Sasso; Pasquale De Luca; Nicola Imperatore; Anna Testa; Roberto de Sire; Elio Biffali; Fabiana Castiglione
Journal:  Nutrients       Date:  2021-04-14       Impact factor: 5.717

9.  IL23R and IL12B SNPs and Haplotypes Strongly Associate with Crohn's Disease Risk in a New Zealand Population.

Authors:  Lynnette R Ferguson; Dug Yeo Han; Alan G Fraser; Claudia Huebner; Wen Jiun Lam; Angharad R Morgan
Journal:  Gastroenterol Res Pract       Date:  2010-12-27       Impact factor: 2.260

Review 10.  Nutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease?

Authors:  Lynnette R Ferguson
Journal:  Front Immunol       Date:  2015-09-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.